Leslie Morgan

Statistics

Publications

Citations

245

H-Index

Active since

2012

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Leslie Morgan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diseases, comparative vaccine safety, and pneumococcal conjugate vaccines.

Publications per year

2012–2024

Publications

A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)

Heather Platt, José F. Cardona, Miwa Haranaka et al. · Vaccine · 2021 · 91 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study

Christophe Hézode, Massimo Colombo, Marc Bourlière et al. · Hepatology · 2017 · 75 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

Heather Platt, Christopher Bruno, Erik Buntinx et al. · The Lancet Infectious Diseases · 2024 · 53 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study

Eugene R. Viscusi, Tara L. Frenkl, Craig T. Hartrick et al. · Current Medical Research and Opinion · 2012 · 26 citations

Medicine, Perioperative Medicine, Surgery +17

1–4 of 4